Bicocca Open Archive

Logo unimib boa

Diral, E., Le Coutre, P., Gottardi, E., Elena, C., Bergamaschi, M., Assouline, S., et al. (2019). Increased Tumour Burden over a 36 Month Period in Chronic Myeloid Leukemia Patients Following Imatinib Discontinuation: Role of Digital PCR. BLOOD, 134(S1), 29-29 [10.1182/blood-2019-125226].

Increased Tumour Burden over a 36 Month Period in Chronic Myeloid Leukemia Patients Following Imatinib Discontinuation: Role of Digital PCR

Piazza R.;Gambacorti-Passerini C.
Ultimo
2019
Editoriale, introduzione, contributo a forum/dibattito
Leukemia Myelogenous Chronic, BCR-ABL Positive, polymerase chain reaction, neoplasms, reverse transcriptase polymerase chain reaction, imatinib mesylate, protein-tyrosine kinase inhibitor, disease remission
English
2019
BLOOD
134
S1
29
29
none
Diral, E., Le Coutre, P., Gottardi, E., Elena, C., Bergamaschi, M., Assouline, S., et al. (2019). Increased Tumour Burden over a 36 Month Period in Chronic Myeloid Leukemia Patients Following Imatinib Discontinuation: Role of Digital PCR. BLOOD, 134(S1), 29-29 [10.1182/blood-2019-125226].
01 - Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/259549
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 2
Social impact